Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
NCT00004940
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Erythropoietic Protoporphyria
Interventions
DRUG:
cysteine hydrochloride
Sponsor
Brigham and Women's Hospital